title: Mesenchymal stem cells: a new trend for cell therapy.
abstract: Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury and immune disorders. In this review, we summarize the recent opinions on methods, timing and cell sources for MSC administration in clinical applications, and provide an overview of mechanisms that are significant in MSC-mediated therapies. Although MSCs for cell therapy have been shown to be safe and effective, there are still challenges that need to be tackled before their wide application in the clinic.
authors.affiliation: Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
authors.forename: Xin
authors.initials: X
authors.lastname: Wei
authors.forename: Xue
authors.initials: X
authors.lastname: Yang
authors.forename: Zhi-peng
authors.initials: ZP
authors.lastname: Han
authors.forename: Fang-fang
authors.initials: FF
authors.lastname: Qu
authors.forename: Li
authors.initials: L
authors.lastname: Shao
authors.forename: Yu-fang
authors.initials: YF
authors.lastname: Shi
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D007154:Immune System Diseases / Q000503:physiopathology / Q000628:therapy*; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000378:metabolism; D013997:Time Factors; D014947:Wounds and Injuries / Q000503:physiopathology / Q000628:therapy*